https://www.selleckchem.com/pr....oducts/cbl0137-cbl-0
ls, especially in low-income countries (LICs), to help inform and direct policy. There is a need for efficient, convenient, and inexpensive methods to accurately diagnose the clinical stage of lung cancer and evaluate the efficacy of chemotherapy in patients with lung cancer. Although growth/differentiation factor 15 (GDF)-15 has great potential as a tumor marker, supporting clinical evidence is still lacking. In this study, we aimed to analyze the relationship between serum GDF15 concentration and the clinical characteristics
Like
Comment
Share
